Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidaxomicin vs Vancomycin for CDI in Immunocompromised Patients
NCT01775397Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Nov 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by Astellas Pharma. Started Nov 2012; status: terminated.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT01775397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01775397.